Best Buy Co Inc vs McKesson Corporation — how do they compare? Best Buy Co Inc trades at $83.25 (market cap $17.55B), while McKesson Corporation trades at $894.95 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 6× Best Buy Co Inc's market cap, and Best Buy Co Inc pays the higher dividend (4.61%). Which is the better fit depends on your goals.
| BBY | MCK | |
|---|---|---|
Market Cap | $17.55B | $105.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $90.17 | $995.69 |
52-Week Low | $55.52 | $659.01 |
Enterprise Value | $19.93B | $111.67B |
Dividend Yield | 4.61% | 0.42% |
Signals from Pluang's Aura AI — not financial advice
BBY trades at $82.43, up 0.52% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 39.1% ROE and trades at a P/E of 15.42, below the sector average. Recent news includes leadership changes and store format tests aimed at growth.
Outlook is mixed: analyst consensus is a hold with a $84.31 price target, but risks include declining revenue and competitive pressures. Upside potential exists if new strategies boost sales, while downside is capped by solid cash flow and dividend payments.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Read more on BBY →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →